Dr. Steven Vold
World-Renowned Ophthalmologist
Dr. Steven Vold is a leading board-certified ophthalmologist who consistently strives to deliver the most advanced techniques and cutting-edge procedures for every patient.
Dr. Steven David Vold is a leading authority in the field of ophthalmology, renowned for his expertise in glaucoma management and surgical innovation. As the Founder and Chief Executive Officer of Vold Vision, P.L.L.C., based in the Orlando, Florida area, Dr. Vold has dedicated his career to advancing eye care through clinical excellence, pioneering research, and comprehensive education. His vision and leadership have established him as a transformative figure in ophthalmology, influencing both patient outcomes and the future of eye care practices.
Dr. Vold holds a Bachelor of Science in Biology, complemented by a minor in Chemistry, from Concordia College in Moorhead, Minnesota. He earned his Doctor of Medicine from the prestigious University of Minnesota Medical School, where he graduated with distinction. Following his medical training, Dr. Vold completed a rigorous transitional internship at Marshfield Clinic/St. Joseph’s Hospital. He then pursued a specialized residency in ophthalmology at Northwestern University Medical School, where he also completed an advanced glaucoma
fellowship under the mentorship of leading experts in the field. To further enhance his leadership acumen, Dr. Vold graduated from the
Physician CEO Business Program at the Kellogg School of Management, Northwestern University, in 2018.
Dr. Vold’s professional trajectory includes significant roles at esteemed institutions across the United States. He has served as a staff physician at Central DuPage Hospital, Edward Hospital, and Mercy St. Mary’s Hospital, where he has earned a reputation for his exceptional patient care and clinical outcomes. His academic appointments include Assistant Professor at Texas A&M College of Medicine and Clinical Assistant Professor at the University of Illinois at Chicago, where he has played a crucial role in shaping the next generation of ophthalmologists.
In his capacity as a leader, Dr. Vold has held prominent positions such as President and CEO of Boozman-Hof Eye Clinic and has been actively involved in clinical practice at Northwest Medical Center and Mercy St. Mary’s Hospital. His leadership extends beyond clinical settings, positioning him as a vital contributor to numerous medical boards and committees dedicated to improving ophthalmic care.
Dr. Vold’s influence in ophthalmology is further underscored by his extensive editorial contributions. He has served as a video editor for the American Glaucoma Society website and as a panel reviewer for leading ophthalmic journals, including Ophthalmic Surgery, Lasers & Imaging and the Middle East African Journal of Ophthalmology. He is currently on the editorial advisory board for Glaucoma Today and Advanced Ocular Care, where he has served as Chief Medical Editor since 2010. His editorial leadership has significantly shaped the discourse around glaucoma treatment and surgical innovation.
As a principal investigator in numerous high-impact studies, Dr. Vold has made groundbreaking contributions to the field of glaucoma. His research focuses on novel surgical techniques and the efficacy of emerging therapies, with funding from leading organizations such as Alcon Research, Ltd., and the Scott & White Research Foundation. He has led pivotal FDA Phase III studies, including the first study site for the CyPass Micro-Stent in the United States, establishing new standards in glaucoma management.
An innovator in the field, Dr. Vold holds multiple patents related to ophthalmic devices and surgical techniques. He has served as a consultant for leading companies in the ophthalmic sector, including Alcon Laboratories and Glaukos Corporation, guiding the development of cutting-edge technologies and therapies that shape the future of eye care.
Dr. Vold’s remarkable contributions to ophthalmology have been recognized through numerous prestigious awards and accolades. He is a life member of the National Registry of Who’s Who and has been consistently recognized in “Guide to America’s Top Ophthalmologists” by Consumers’ Research Council of America since 2002. As a pioneer in glaucoma surgery, he has been the first surgeon to perform several groundbreaking procedures in the United States, reflecting his commitment to advancing surgical techniques and improving patient outcomes.
Dr. Vold is deeply committed to medical education, having taught numerous courses and lectures at various medical institutions. He has served as an invited speaker at national and international conferences, sharing his expertise on glaucoma management and innovative surgical techniques. His dedication to mentorship ensures that new generations of ophthalmologists are equipped with the knowledge and skills necessary to excel in their practices.
Dr. Steven David Vold stands at the forefront of ophthalmology, recognized not only as a leading expert in glaucoma but also as a visionary leader dedicated to advancing eye care through innovation, education, and outstanding clinical practice. His unwavering commitment to excellence and patient care continues to set new benchmarks in the field of ophthalmology, making a profound impact on the lives of patients and practitioners alike.
Patients have come from 50 states & over 25 different countries to have Dr. Vold personally perform their surgery.
Your Journey to Better Vision Begins Here
If you are seeking elite eye care, advanced technology, and a highly customized patient experience, VOLD Vision welcomes patients from across the globe. Let us be your destination for sight, comfort, and clarity. Our patient care counselors are available by text, phone, or email and no question is too small for them to answer. To schedule a consultation, fill out the consultation request form below, or call or text us at (407) 309-2788.
